Drug-induced corneal damage.
[No authors listed]
Prescrire Int. 2014 Apr;23(148):97-100.
Drug-induced corneal epithelial changes.
Raizman MB, Hamrah P, Holland EJ, Kim T, Mah FS, Rapuano CJ, Ulrich RG.
Surv Ophthalmol. 2017 May-Jun;62(3):286-301. doi: 10.1016/j.survophthal.2016.11.008. Epub 2016 Nov 24.
Macular Corneal Dystrophy: An Updated Review.
Singh S, Das S, Kannabiran C, Jakati S, Chaurasia S.
Curr Eye Res. 2021 Jun;46(6):765-770. doi: 10.1080/02713683.2020.1849727. Epub 2020 Nov 29.
Drug-induced corneal complications.
Hollander DA, Aldave AJ.
Curr Opin Ophthalmol. 2004 Dec;15(6):541-8. doi: 10.1097/01.icu.0000143688.45232.15.
Deposition keratopathy.
Panthagani J, MacDonald T, Bruynseels A, Madathilethu SC, Jenyon T.
Br J Hosp Med (Lond). 2022 Jul 2;83(7):1-13. doi: 10.12968/hmed.2021.0237. Epub 2022 Jul 11.
Systemic diseases and the cornea.
Shah R, Amador C, Tormanen K, Ghiam S, Saghizadeh M, Arumugaswami V, Kumar A, Kramerov AA, Ljubimov AV.
Exp Eye Res. 2021 Mar;204:108455. doi: 10.1016/j.exer.2021.108455. Epub 2021 Jan 21.
The genetics of the corneal dystrophies.
Aldave AJ.
Dev Ophthalmol. 2011;48:51-66. doi: 10.1159/000324077. Epub 2011 Apr 26.
Corneal neovascularization: updates on pathophysiology, investigations & management.
Sharif Z, Sharif W.
Rom J Ophthalmol. 2019 Jan-Mar;63(1):15-22.
RNA-Seq-based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy.
Nakagawa T, Tokuda Y, Nakano M, Komori Y, Hanada N, Tourtas T, Schlötzer-Schrehardt U, Kruse F, Tashiro K, Koizumi N, Okumura N.
Sci Rep. 2023 May 27;13(1):8647. doi: 10.1038/s41598-023-35468-y.
Clinical corneal confocal microscopy.
Chiou AG, Kaufman SC, Kaufman HE, Beuerman RW.
Surv Ophthalmol. 2006 Sep-Oct;51(5):482-500. doi: 10.1016/j.survophthal.2006.06.010.
